Peter Riederer,Amos D. Korczyn,Sameh S. Ali,Ovidiu Bajenaru,Mun Seong Choi,Michael Chopp,Vesna Dermanovic-Dobrota,Edna Grünblatt,Kurt A. Jellinger,Mohammad Amjad Kamal,Warda Kamal,Jerzy Leszek,Tanja Maria Sheldrick-Michel,Gohar Mushtaq,Bernard Meglic,Rachel Natovich,Zvezdan Pirtosek,Martin Rakusa,Melita Salkovic-Petrisic,Reinhold Schmidt,Angelika Schmitt,G. Ramachandra Sridhar,László Vécsei,Zyta Beata Wojszel,Hakan Yaman,Zheng G. Zhang,Tali Cukierman-Yaffe

Abstract:The prevalence of both Alzheimer’s disease (AD) and vascular dementia (VaD) is increasing with the aging of the population. Studies from the last several years have shown that people with diabetes have an increased risk for dementia and cognitive impairment. Therefore, the authors of this consensus review tried to elaborate on the role of diabetes, especially diabetes type 2 (T2DM) in both AD and VaD. Based on the clinical and experimental work of scientists from 18 countries participating in the International Congress on Vascular Disorders and on literature search using PUBMED, it can be concluded that T2DM is a risk factor for both, AD and VaD, based on a pathology of glucose utilization. This pathology is the consequence of a disturbance of insulin-related mechanisms leading to brain insulin resistance. Although the underlying pathological mechanisms for AD and VaD are different in many aspects, the contribution of T2DM and insulin resistant brain state (IRBS) to cerebrovascular disturbances in both disorders & Peter Riederer peter.riederer@mail.uni-wuerzburg.de Amos D. Korczyn amoskor@tau.ac.il Sameh S. Ali Sameh.ali@zewailcity.edu.eg; ssali@ucsd.edu Ovidiu Bajenaru ovalbajenaru@yahoo.com Mun Seong Choi muschoi08@gmail.com; muschoi@chol.com Michael Chopp michael.chopp@gmail.com Vesna Dermanovic-Dobrota Vesna.djermanovic.dobrota@zg.t-com.hr Edna Grünblatt edna.gruenblatt@kjpd.uzh.ch Kurt A. Jellinger kurt.jellinger@univie.ac.at Mohammad Amjad Kamal prof.makamal@lycos.com Warda Kamal akengne@georgeinstitute.org.au Jerzy Leszek jerzy.leszek@umed.wroc.pl Tanja Maria Sheldrick-Michel tanjamichel@yahoo.com Gohar Mushtaq gmushtaq2001@gmail.com Bernard Meglic bernard.meglic@kclj.si Rachel Natovich rnatovich@gmail.com Zvezdan Pirtosek zvezdan.pirtosek@kclj.si Martin Rakusa ris101@gmail.com Melita Salkovic-Petrisic melita.salkovic.petrisic@mef.hr Reinhold Schmidt reinhold.schmidt@kfunigraz.ac.at Angelika Schmitt Schmitt_A3@ukw.de G. Ramachandra Sridhar sridharvizag@gmail.com László Vécsei vecsei.laszlo@med.u-szeged.hu Zyta Beata Wojszel wojszel@umb.edu.pl

IRS 2 Insulin receptor substrate-2